Kwality Pharmaceuticals Ltd.

BSE: 539997 SECTOR: Pharmaceuticals & Drugs  30k   319   13

295.10
+1.30 (0.44%)
BSE: Today, 05:10 PM

Price Summary

Today's High

₹ 306

Today's Low

₹ 293

52 Week High

₹ 508.8

52 Week Low

₹ 0

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

306.2 Cr.

Enterprise Value

349.34 Cr.

No. of Shares

1.04 Cr.

P/E

15.73

P/B

1.52

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  193.93

CASH

10.87 Cr.

DEBT

54.01 Cr.

Promoter Holding

54.74 %

EPS (TTM)

₹  18.76

Sales Growth

74.43%

ROE

98.61 %

ROCE

97.26%

Profit Growth

678.76 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year74.43%
3 Year40.3%
5 Year36.77%

Profit Growth

1 Year678.76%
3 Year151.49%
5 Year103.51%

ROE%

1 Year98.61%
3 Year49.07%
5 Year37.23%

ROCE %

1 Year97.26%
3 Year47.45%
5 Year36.64%

Debt/Equity

0.2972

Price to Cash Flow

4.86

Interest Cover Ratio

54.1912814607666

CFO/PAT (5 Yr. Avg.)

0.691281237949681

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2023 54.74 0
Dec 2022 54.45 0
Sep 2022 54.45 0
Jun 2022 54.45 0
Mar 2022 54.43 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 40.3034516973908% for the Past 3 years.
  • Company has been maintaining healthy ROE of 49.068339783371% over the past 3 years.
  • Company has been maintaining healthy ROCE of 47.4460902919999% over the past 3 years.
  • Company has a healthy Interest coverage ratio of 54.1912814607666.
  • Company’s PEG ratio is 0.0231710232655439.
  • The company has an efficient Cash Conversion Cycle of 16.4520118638086 days.
  • The company has a high promoter holding of 54.74%.

 Limitations

 Looks like the company does not have any serious limitations.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2022 Sep 2022 Dec 2022 Mar 2023
Net Sales 70.22 55.96 56.01 68.8
Total Expenditure 52.2 40.39 40.84 57.29
Operating Profit 18.02 15.57 15.17 11.52
Other Income 0.38 0.75 0.35 1.46
Interest 1.22 1.18 1.95 1.67
Depreciation 3.13 3.83 3.54 4.42
Exceptional Items 0 0 0 -16.53
Profit Before Tax 14.05 11.32 10.03 -9.63
Tax 3.5 2.27 2.8 -2.28
Profit After Tax 10.55 9.05 7.23 -7.36
Adjusted EPS (Rs) 10.17 8.72 6.97 -7.09

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Net Sales 136.83 165.15 138.68 261.5 456.13
Total Expenditure 125.33 149.9 124.55 232.23 284.29
Operating Profit 11.5 15.25 14.14 29.27 171.85
Other Income 1.1 0.93 3.92 1.59 3.51
Interest 2.19 2.22 2.52 2.62 3.04
Depreciation 2.86 3.06 4.39 6.44 10.64
Exceptional Items 0 0 0 0 0
Profit Before Tax 7.55 10.9 11.14 21.8 161.67
Tax 2.87 3.35 2.71 6.38 41.63
Net Profit 4.68 7.55 8.43 15.42 120.05
Adjusted EPS (Rs.) 4.51 7.27 8.13 14.86 115.69

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Equity and Liabilities
Share Capital 10.38 10.38 10.38 10.38 10.38
Total Reserves 20.74 28.29 36.72 52.13 172.18
Borrowings 4.11 7.01 10.18 18.26 20.29
Other N/C liabilities 0.76 0.64 9.6 9.82 10.21
Current liabilities 61.7 60.67 67.61 78.15 129.62
Total Liabilities 97.69 106.99 134.48 168.75 342.68
Assets
Net Block 19.27 28.02 41.63 55.52 90.77
Capital WIP 0 0 0 2.89 12.15
Intangible WIP 0 0 0 0 0
Investments 4.11 4.64 4.2 4.28 4.33
Loans & Advances 0.12 0.12 0.12 0.17 8.11
Other N/C Assets 0.07 0.03 0 0 0
Current Assets 74.12 74.17 88.53 105.88 227.32
Total Assets 97.69 106.99 134.48 168.75 342.68
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Profit from operations 7.55 10.9 11.14 21.8 161.67
Adjustment 4.61 4.74 6.27 8.98 13.51
Changes in Assets & Liabilities -9.2 0.76 -9.06 1.96 -70.77
Tax Paid -3.06 -3.44 -2.71 -6.38 -41.35
Operating Cash Flow -0.09 12.96 5.63 26.36 63.06
Investing Cash Flow -6.2 -11.8 -17.13 -23.2 -62.98
Financing Cash Flow 4.96 -1.91 12.36 0.83 5.66
Net Cash Flow -1.33 -0.75 0.87 3.99 5.74

Corporate Actions

Investors Details

PARTICULARS Mar 2022% Jun 2022% Sep 2022% Dec 2022% Mar 2023%
Promoters 54.43 54.45 54.45 54.45 54.74
ramesh arora 30.86 28.58 28.58 28.58 28.58
ajay kumar arora - - - - -
ajay arora 13.45 13.45 13.45 13.45 13.45
aditya arora 6.41 1.37 1.37 1.37 1.37
anu mehra - 2.32 2.32 2.32 2.32
anju arora 1.31 1.31 1.31 1.31 1.31
geeta arora 1.07 1.07 1.07 1.07 1.07
aarti bajaj - 0.90 - 0.90 0.90
aarti bajaj - - 0.90 - -
jugal kishore huf 0.89 0.89 0.89 0.89 0.89
sachin seth 0.25 0.25 0.25 0.25 0.25
PARTICULARS Mar 2022% Jun 2022% Sep 2022% Dec 2022% Mar 2023%
Investors 45.57 45.55 45.55 45.55 45.26
t r metals private... - 13.31 13.31 13.31 13.31
rkk portfolio priv... 12.56 - - - -
deepak bansal 10.54 - - - 5.92
guiness securities... - 6.16 5.87 - -
ways vinimay priva... - - - 5.44 5.44
ashish kacholia 1.36 - - - -
jani bhasha shaik 1.45 - - 1.82 1.82
nizamuddin shaik 1.16 - 1.16 1.39 1.39
neeraj jain - 1.16 1.16 - -
ashok lakhani - 1.04 1.04 1.04 1.04
onkar singh 1.01 - - - -

Annual Reports

Ratings & Research Reports

Company Presentations

  • PresentationQ4FY22 21 Jun 2022

Kwality Pharma Stock Price Analysis and Quick Research Report. Is Kwality Pharma an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Kwality Pharma and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Its cash from the operating activity was Rs 63.0607 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Kwality Pharma has a Debt to Equity ratio of 0.2972 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Kwality Pharma , the EPS growth was 678.765624894824 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Kwality Pharma has OPM of 37.6747850839538 % which is a good sign for profitability.
     
  • ROE: Kwality Pharma have a healthy ROE of 98.6145110783254 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
Brief about Kwality Pharma

X